Conlon et al. (13) showed that when recombinant human IL-15 was given to patients with metastatic malignant tumors, IL-15 could alter the homeostasis of lymphocyte subsets in blood and increase the content of NK cells significantly. This evidence concerns the gene IL15 and cancer.